Nufarm share price surges 6% as Macquarie snaps up a bargain

The Nufarm Ltd (ASX: NUF) share price closed 6.03% higher on the ASX yesterday as Macquarie Group Ltd (ASX: MQG) bought up big in the Aussie agribusiness group.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nufarm Limited (ASX: NUF) share price closed 6.03% higher on the ASX yesterday as Macquarie Group Ltd (ASX: MQG) bought up big in the Aussie agribusiness group. 

a woman

Why did the Nufarm share price surge higher?

The Nufarm share price closed higher at $4.92 per share yesterday as Macquarie increased its already substantial equity stake in the ASX chemicals group.

As per Nufarm's ASX release yesterday, Macquarie purchased nearly 9 million additional Nufarm shares to increase its voting power by 2%.

Previously, Macquarie owned 19,294,099 Nufarm shares but has since increased its voting stake to 7.38% following yesterday's purchase. 

The largest holder of Nufarm shares within the Macquarie Group is Macquarie Bank Ltd with 23,451,739, with the rest largely within the group's investment management arms. 

While it's hard to say why Macquarie has been buying up more Nufarm shares, I think it could be a case of opportunistic buying from the Aussie wealth management group. 

How has the Nufarm share price performed in 2019?

I think Nufarm's recent share price devaluation is a key factor, with the current $4.92 per share a long way shy of Nufarm's 52-week high of $7.69, despite a record start to the year for the Aussie stock market.

One of the big reasons behind the company's share price falling 20.6% so far this year has been the ongoing Monsanto-Bayer Roundup lawsuits in the United States (US) and around the globe. 

The company is subject to over 11,000 lawsuits over its weed killer product, with allegations that it is the cause of Non-Hodgkin lymphoma in many of the plaintiffs. 

Monsanto has already lost several of its early cases in the US, however, these remain before the courts and subject to a lengthy appeals process. 

The concern for Nufarm is whether or not its similar glyphosate-based products could come under the same scrutiny in Australia, the occurrence of which could have a material financial impact on the company's expenses. 

However, with no allegations or lawsuits against the company as yet, Macquarie has clearly taken the chance to buy what they see as a bargain in the S&P/ASX 200 (INDEXASX: XJO) index.

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

ASX 200 shares with renewed buy ratings this week

Brokers have signalled ongoing confidence in Zip, ANZ, Coles, and several other ASX 200 shares.

Read more »

A man in trendy clothing sits on a bench in a shopping mall looking at his phone with interest and a surprised look on his face.
Share Market News

5 things to watch on the ASX 200 on Friday

Will the market end the week on a high? Let's find out.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

4 ASX 200 shares newly upgraded this week

As the Iran war and fuel crisis continues, some ASX 200 shares have attracted upgrades from the experts.

Read more »

A smiling woman puts fuel into her car at a petrol pump.
Broker Notes

Up 60% in a year, 3 reasons to buy Ampol shares today

A leading analyst forecasts more outperformance from Ampol’s surging shares. But why?

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
52-Week Highs

Are these ASX stocks hitting 52-week highs a buy, hold, or sell?

Can these market winners keep rallying?

Read more »

A female superhero dressed in shiny green with a mask leaps in the sky with leg and arm outstretched in a leaping action.
Share Gainers

WiseTech shares rocket 11% higher today: Buy, sell or hold?

It looks like we could see a lot more out of WiseTech shares over the next few months!

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
52-Week Highs

3 ASX 200 titans charging to new one-year-plus highs today

Investors just sent these three ASX 200 titans surging to new 52-week-plus highs. But why?

Read more »

Smiling worker in metal landfill.
Broker Notes

Up 45% in a year, 3 reasons to buy Sims shares today

A leading analyst forecasts more outperformance from Sims' soaring share price. But why?

Read more »